2010
DOI: 10.3748/wjg.v16.i45.5746
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial susceptibility ofHelicobacter pyloristrains isolated from patients in Shiraz, Southern Iran

Abstract: We found a moderate rate of primary resistance to metronidazole. However, a high MIC (> 256 mg/L) which was found in 71% of the isolates is considerable. In the case of amoxicillin, an increased resistance rate of 20% is worrying. Resistance to clarithromycin and tetracycline is also emerging among the H. pylori strains in our region.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
28
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 34 publications
(30 citation statements)
references
References 39 publications
1
28
1
Order By: Relevance
“…These breakpoints were used based on the recommendations of the National Committee for Clinical Laboratory Standards (NCCLS) (11,(18)(19)(20)(21)(22).…”
Section: Resultsmentioning
confidence: 99%
“…These breakpoints were used based on the recommendations of the National Committee for Clinical Laboratory Standards (NCCLS) (11,(18)(19)(20)(21)(22).…”
Section: Resultsmentioning
confidence: 99%
“…MNZ is an inexpensive drug frequently used to treat not only H. pylori infection but also other infections such as intestinal parasites and periodontal and gynecologic diseases, which are common in developing countries such as Bangladesh [21,23]. Although in vitro resistance to MNZ may not accurately reflect in vivo resistance and should be confirmed by measuring blood drug concentrations [27], regimens that include MNZ are not a preferable choice in populations with >40% resistance to this drug [28]. In Asia, only Japan, Thailand, and Malaysia have populations with <40% MNZ resistance [7], and preferentially use the PPI + CAM + MNZ regimen recommended by the Maastricht III Consensus Report.…”
Section: Discussionmentioning
confidence: 99%
“…Multiple antibiotic resistances were observed in 8 of 27(29.6%) resistant isolates (17). In Shiraz, South of Iran, resistances of H.pylori were 44%, 20%, 3%, and 5% for metronidazole, clarithromycin, tetracycline, and amoxicillin, respectively (18). The prevalence rate of metronidazole resistance between H. pylori strains is greatly variable, and is higher in developing countries than developed worlds (19).…”
Section: Discussionmentioning
confidence: 99%